We are live on ! Find out more
VNRX icon

VolitionRx Ltd

34 hedge funds and large institutions have $8.99M invested in VolitionRx Ltd in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,271% more call options, than puts

Call options by funds: $192K | Put options by funds: $14K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0.51%0.51% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

11% less funds holding

Funds holding: 3834 (-4)

26% less capital invested

Capital invested by funds: $12.2M → $8.99M (-$3.23M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
8
Reduced
8
Closed
6
Calls
$192K
Puts
$14K
Net Calls
+$178K
Net Calls Change
-$67K

VNRX Hedge Fund Activity: Q2 2023 in Review

34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2023, worth a combined $8.99M — down 26% from $12.2M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VNRX and 2 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Geode Capital Management, adding an estimated $284K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $186K sold.

  • 34 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2023, down from 38 in Q1 2023.
  • Funds reported $8.99M of VolitionRx Ltd stock for Q2 2023, down 26% quarter-over-quarter.
  • 2 funds opened new VolitionRx Ltd positions in Q2 2023 and 6 closed out, a net change of -4 holders.
  • The largest VolitionRx Ltd buyer in Q2 2023 was Geode Capital Management, an estimated $284K added.
  • The largest VolitionRx Ltd seller in Q2 2023 was Susquehanna International Group, an estimated $186K sold.

Based on aggregated 13F filings for Q2 2023.